Leukemia inhibitory factor drives malignant progression in lung squamous cell carcinoma via the PI3K/AKT/GSK-3β/β-catenin axis
{{output}}
Leukemia inhibitory factor (LIF) is an established oncogenic driver in multiple cancers. However, its functional contribution and mechanistic underpinnings in lung squamous cell carcinoma (LSCC) remain incompletely defined. To delineate the role of LIF in LSCC... ...
